肿瘤患者心血管护理的一个重要优先事项是降低发病率和死亡率,并通过跨学科努力提高癌症幸存者的生活质量。在过去的几十年中,癌症患者的生存率显着提高。尽管如此,从长远来看,幸存者更有可能死于心血管疾病,次要,不仅对癌症疗法的潜在毒性,还有癌症的生物学。在这种情况下,基础和转化研究的努力对于理解癌症患者和幸存者心血管疾病的分子机制至关重要,并确定可以预防和治疗这两种疾病的新治疗靶点。这篇综述旨在强调我们目前对癌症和心脏之间的代谢相互作用的理解。包括潜在的治疗靶点。还提供了可以支持研究和临床管理的成像技术的概述。最后,本综述重点介绍了在心脏肿瘤学背景下促进我们对代谢的理解所必需的机遇和挑战.
An important priority in the cardiovascular care of oncology patients is to reduce morbidity and mortality, and improve the quality of life in cancer survivors through cross-disciplinary efforts. The rate of survival in cancer patients has improved dramatically over the past decades. Nonetheless, survivors may be more likely to die from cardiovascular disease in the long term, secondary, not only to the potential toxicity of cancer therapeutics, but also to the biology of cancer. In this context, efforts from basic and translational studies are crucial to understanding the molecular mechanisms causal to cardiovascular disease in cancer patients and survivors, and identifying new therapeutic targets that may prevent and treat both diseases. This review aims to highlight our current understanding of the metabolic interaction between cancer and the heart, including potential therapeutic targets. An overview of imaging techniques that can support both research studies and clinical management is also provided. Finally, this review highlights opportunities and challenges that are necessary to advance our understanding of metabolism in the context of cardio-oncology.